Organization
University Hospital of Lausanne
3 abstracts
Abstract
High-dimensional longitudinal immune profiling uncovers a dual role of the CXCL9/CXCR3, CXCL13/CXCR5, and CCL11/CCL3 axis in the coupling of immune-related adverse events to immune checkpoint inhibitor response.Org: CHUV, Lausanne University Hospital, Department of Oncology, National Taiwan University Hospital, University of Lausanne, University Hospital of Lausanne,
Abstract
Prognostic factors of long-term outcomes after primary chemo-radiotherapy in non-metastatic anal squamous cell carcinoma: An international bicentric cohort.Org: Oncology Unit S. Chiara Hospital, Trento, Italy, Gastroenterology Hospital, Paris-St Joseph Hospital, Hospital de Gastroenterología Carlos Bonorino Udaondo, University Hospital of Lausanne,
Abstract
Feasibility of treatment with another CDK4/6 inhibitor after severe ribociclib liver toxicity.Org: EHC, Morges, Switzerland, University Hospital 12 de Octubre, Institut Curie, Saint Cloud, France, Centre GF Leclercq,